Panic Disorder

212 registered clinical trials studyying Panic Disorder — 26 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	The Use of a FDA Cleared, Drug-free, Breathing System for Anxiety and Panic Disorders in Children and Teens NCT02998502	Johns Hopkins University	N/A
Not Yet Recruiting	Testing a Precision Psychotherapy System for Low-income Patients NCT05118594	National Council of Scientific and Technical Research, Argentina	N/A
Recruiting	Internet-Delivered Cognitive Behavioral Intervention for Youths With Anxiety Disorders NCT06661460	Lund University	N/A
Not Yet Recruiting	Investigation of Pathogenic Gut Microbiota Patterns in Anxiety, Depression and Panic Disorders NCT07268729	University of Toronto	—
Recruiting	Implementing Team-Based Treatment for Pediatric Anxiety in Community Mental Health Settings NCT06934525	Bradley Hospital	N/A
Not Yet Recruiting	Psychoeducation Based on Acceptance and Commitment Therapy NCT06704399	Muğla Sıtkı Koçman University	N/A
Recruiting	IL-33, sST2, and CRP in Panic Disorder NCT07444879	Elazığ Mental Health and Diseases Hospital	—
Recruiting	Comparative Effectiveness of Internet-based Versus Parent-Coached Cognitive-Behavioral Therapy For Children an NCT07024758	Baylor College of Medicine	N/A
Recruiting	Stepped Versus Stratified Care for Anxiety Disorders in Youth NCT06942429	Region Skane	N/A
Recruiting	Mindful Self-compassion for Anxiety and Depression: Impact of Delivery Method NCT07028216	Georgetown University	N/A
Not Yet Recruiting	Investigations of Factors Associated With Treatment Response and Prognosis in Anxiety Disorders NCT06773585	Kangbuk Samsung Hospital	—
Completed	α-N-acetylgalactosaminidase Levels in Panic Disorder NCT07424911	Elazığ Mental Health and Diseases Hospital	—
Recruiting	Analyzing the Benefits of Using SYMPTOMS-JIT for in Vivo Exposure in Anxiety Disorders NCT06788119	Universitat Jaume I	N/A
Completed	Epidemiological Study on the Prevalence of Mental Disorders in Slovakia NCT07129408	Comenius University	—
Recruiting	LHC-CIDI-5 in Hong Kong NCT06804525	The University of Hong Kong	—
Recruiting	Neurofeedback Enhanced Cognitive Reappraisal Training - Phase 4 NCT06563310	University of Michigan	N/A
Recruiting	Qigong and Multicomponent Exercise in Panic Disorder NCT07439224	Dokuz Eylul University	N/A
Completed	Self-Guided CBT Mobile App for Treatment-Resistant Panic Disorder (CBT) Cognitive Behavioral Therapy NCT07391943	Universidade Federal do Rio de Janeiro	—
Recruiting	Efficacy and Safety of HB-1 for Panic Disorder NCT06483789	Honeybrains Biotech LLC	Phase 2
Completed	Neurobehavioral Correlates of Caffeine on Anxiety, Avoidance and Interoception in Healthy Individuals and Pani NCT06145490	Uppsala University	N/A
Recruiting	The Effectiveness of Transdiagnostic CBT Protocol on Anxiety Disorders NCT06422728	Ibn Haldun University	N/A
Completed	Neurofeedback Enhanced Cognitive Reappraisal Training NCT06132659	University of Michigan	N/A
Not Yet Recruiting	Efficacy of Hydroxyzine for Patients With Panic Disorder NCT05737511	Sultan Qaboos University	Phase 4
Active Not Recruiting	Evaluation of Family-Based Behavioral Treatments for Youth With Anxiety and Obsessive-Compulsive Disorder NCT05967468	Baylor College of Medicine	N/A
Completed	A Study to Evaluate Efficacy, Safety, and Tolerability of Darigabat in Participants With Panic Disorder NCT05941442	AbbVie	Phase 2
Completed	Guided and Traditional Cognitive Behavioral Therapy Protocol for Resistant Panic NCT07247955	Universidade Federal do Rio de Janeiro	N/A
Completed	Level of Physical Activity and Fear Learning NCT05203731	NYU Langone Health	N/A
Recruiting	CO2 Reactivity as a Biomarker of Non-Response to Exposure-Based Therapy NCT05467683	University of Texas at Austin	N/A
Active Not Recruiting	Clinical Trial of a Group Self-management Support Program for Anxiety Disorders NCT05124639	Université de Sherbrooke	N/A
Recruiting	Respiratory Training in the Treatment of Transdiagnostic Pathological Anxiety NCT05427708	University of Texas at Austin	N/A
Completed	Clinical Markers of Panic and Generalized Anxiety Disorder NCT06071819	University of Milano Bicocca	—
Completed	Effects of Caffeine on Anxiety, Emotional Processing, Approach-avoidance Behavior, and Interoception in Panic NCT05261594	Uppsala University	N/A
Active Not Recruiting	Transdiagnostic Versus Diagnosis-specific Cognitive-behavioral Therapy NCT05249543	Karolinska Institutet	N/A
Active Not Recruiting	Treatment of Anxiety Disorders With Trigeminal Nerve Stimulation NCT04931134	Dr. Rafael Freire	N/A
Completed	Safety and Efficacy of HB-1 for Panic Disorder NCT05071430	Honeybrains Biotech LLC	Phase 2
Recruiting	Mindful Self-Compassion for Anxiety Disorders and Depression NCT05671419	Georgetown University	N/A
Recruiting	Validating an Autonomous Interactive Internet-Based Delivery of an Empirically Supported Cognitive Behavioral NCT05117255	University of Minnesota	N/A
Completed	Relationship Between Repetitive Negative Thinking and CBT Outcomes NCT06370559	South London and Maudsley NHS Foundation Trust	—
Active Not Recruiting	Physical Exercise as Adjunctive Therapy for Affective Disorder and Anxiety NCT05157386	Region Stockholm	—
Unknown	Cannabidiol for the Treatment of Anxiety Disorders: An 8-Week Pilot Study NCT03549819	McMaster University	Phase 3
Active Not Recruiting	Evaluating Clinical Routines for ICBT NCT05321628	Karolinska Institutet	N/A
Recruiting	Effects and Cost-effectiveness of e-Meistring - a Guided Internet-delivered Psychological Treatment NCT05868135	St. Olavs Hospital	—
Completed	Parent-based Treatment for Youth With Anxiety and Obsessive-compulsive Disorder NCT04922502	Baylor College of Medicine	N/A
Recruiting	Evaluation of Primary Care Behavioral Health (PCBH) With the Addition of Self-help CBT - A Randomized Multicen NCT04900064	Linnaeus University	N/A
Unknown	Xenon Inhalation for Treatment of Panic Disorder NCT04432155	Nobilis Therapeutics Inc.	Phase 2 / Phase 3
Withdrawn	Cannabinoids for the Treatment of Anxiety Disorders: An 8-Week Pilot Study NCT04569760	McMaster University	Phase 3
Terminated	The Relationship Between Panic Attack Symptoms and Atrial Fibrillation Episodes. NCT04634461	State University of New York at Buffalo	—
Terminated	Cognitive Behavioral Therapy Group for Older Adults Delivered by Telethealth NCT04714164	Nova Scotia Health Authority	N/A
Unknown	Development of Mental Health Outcomes Following the 2020 Petrinja Earthquake NCT04911933	Neuropsychiatric Hospital dr Ivan Barbot	N/A
Completed	A Trial of the Effect of CVL-865 on Panic Symptoms Induced by Carbon Dioxide Inhalation in Healthy Subjects NCT04592536	Cerevel Therapeutics, LLC	Phase 1
Unknown	An Augmented Training Program for Preventing Post-Traumatic Stress Injuries Among Diverse Public Safety Person NCT05530642	University of Regina	N/A
Completed	Mobile-assisted Case Management for Panic Disorder NCT05832905	En Chu Kong Hospital	—
Unknown	Efficacy of an App-based CBT Featuring Virtual Reality for Anxiety Disorders NCT05510804	Bartosz of Zurowski	N/A
Completed	Transdiagnostic Internet-delivered REBT Intervention for Adolescents' Internalizing Problems NCT04179526	Babes-Bolyai University	N/A
Unknown	Physical and Psychological Health Trajectories in the Context of Coronary Heart Disease NCT04433832	Laval University	—
Completed	The Effect Of Transcranial Direct Current Stimulation In Panic Disorder NCT04160806	Istanbul University	N/A
Unknown	Perinatal Mental Health Care in Switzerland NCT04185896	Bern University of Applied Sciences	—
Completed	Investigations of Amygdala Function Using Neurophysiological Recording and Stimulation NCT03958903	Stanford University	N/A
Recruiting	Risk and Resiliency Factors in the RCMP: A Prospective Investigation NCT05527509	University of Regina	N/A
Completed	A 14 Week, Randomized, Placebo-Controlled Cross-Over Study of Methylphenidate Hydrochloride Controlled Release NCT03785223	McMaster University	Phase 4
Unknown	Floatation-REST (Reduced Environmental Stimulation Therapy) for Anxiety and Depression NCT03899090	Laureate Institute for Brain Research, Inc.	N/A
Unknown	Exosomal microRNAs as a Biomarker in Panic Disorder and in Response to CBT NCT04029740	Hebrew University of Jerusalem	N/A
Unknown	RECOVERY: A Transdiagnostic Intervention for Anxiety and Depression NCT03917550	West University of Timisoara	N/A
Unknown	Construction of a Questionnaire on Panic Disorder and Agoraphobia NCT03885453	Ulrike Willutzki	—
Completed	Walking or High Intensity Exercise for Anxiety NCT03819426	NYU Langone Health	N/A
Completed	A Validation Study of Mobile Virtual Reality-Based Self-Care and Exposure Therapy Contents for the Treatment o NCT04985019	Gangnam Severance Hospital	N/A
Unknown	Measuring Physiology to Determine if Pre-panic Attack Detection is Possible NCT03360578	Medical Psychology Center	—
Unknown	Improving Access to Child Anxiety Treatment NCT03528109	Bradley Hospital	N/A
Completed	Treatments for Anxiety: Meditation and Escitalopram NCT03522844	Georgetown University	Phase 4
Completed	Predicting Treatment Response to Exposure Therapy Using Carbon Dioxide NCT03925987	Laureate Institute for Brain Research, Inc.	N/A
Completed	Adapting an Effective CBT for Comorbidity to a Computer-Delivered Format NCT03300232	University of Minnesota	N/A
Completed	Bioequivalence Study of Paroxetine Tablets and Paxil® Under Fasting and Fed Conditions in Chinese Healthy Volu NCT03504475	Beijing Tongren Hospital	Phase 1
Unknown	Rumination Focus Cognitive Behavior Therapy NCT03507114	West University of Timisoara	N/A
Recruiting	Neurobiological Markers of Treatment Response for Anxiety and OCD NCT05663489	Haukeland University Hospital	—
Completed	Collabri Flex - Effect of Collaborative Care for People With Anxiety Disorders in General Practice NCT03113175	Amager Hospital	N/A
Completed	Pragmatic Collaborative Care for Cardiac Inpatients With Depression or Anxiety NCT03118752	Massachusetts General Hospital	N/A
Completed	The Association Between Physical Sensations and Thinking Styles NCT03233542	Ruhr University of Bochum	N/A
Unknown	Neuroimaging of Pavlovian Fear Conditioning Processes in Patients With Pathological Anxiety NCT03498599	University of Texas at Austin	N/A
Completed	The Modular Protocol for Mental Health (MPMH) NCT03143634	Medical Research Council Cognition and Brain Sciences Unit	Phase 1 / Phase 2
Completed	Effect of Mindfulness Meditation on Physiological Response to Unpredictable Stimuli NCT03206437	Georgetown University	N/A
Unknown	Effectiveness & Cost-effectiveness of Internet-delivered Interventions for Depression and Anxiety Disorders in NCT03188575	Silver Cloud Health	N/A
Completed	Improving Access to the Treatment of Anxiety and Depression Among Young Adults NCT03156556	Universite de Moncton	N/A
Completed	CBT for Anxiety Sensitivity vs. Disorder-specific CBT: An RCT NCT03015285	Nova Scotia Health Authority	N/A
Completed	Dimensional Brain Behavior Predictors of CBT Outcomes in Pediatric Anxiety NCT02810171	University of Michigan	N/A
Completed	Trans-diagnostic Group CBT vs. Standard Group CBT for Depression, Social Anxiety and Agoraphobia/Panic Disorde NCT02954731	Psychiatric Research Unit, Region Zealand, Denmark	N/A
Completed	Examining the Effects of Reduced Environmental Stimulation on Anxiety NCT03051074	Laureate Institute for Brain Research, Inc.	N/A
Completed	Attitudes of Professionals and the General Public in Israel Regarding ICBT NCT04659577	Hebrew University of Jerusalem	N/A
Completed	Clinical Trial of Transdiagnostic Cognitive-Behavior Therapy for Anxiety Disorders NCT02811458	Université de Sherbrooke	N/A
Completed	Transdiagnostic REBT Prevention Program for Adolescents NCT02756507	Babes-Bolyai University	N/A
Completed	The Role of Orexin in Human Panic Disorder NCT02593682	University of California, San Francisco	Phase 4
Unknown	Internet-delivered Transdiagnostic Intervention for Anxiety and Depression NCT02739607	West University of Timisoara	N/A
Unknown	Disruption of Memory Reconsolidating as a Treatment for Panic Disorder NCT02631694	VU University of Amsterdam	Phase 2
Completed	Integrated Mental Health Care and Vocational Rehabilitation to Individuals on Sick Leave Due to Anxiety and De NCT02872051	Amager Hospital	N/A
Unknown	Threat-Avoidance Learning in Anxiety Patients NCT02336802	KU Leuven	—
Unknown	Different Neural Circuit Mechanisms Between Cognitive Therapy and Behavior Therapy for Patients With Panic Dis NCT03199625	Nanjing Medical University	Phase 2
Completed	A Brief Version of Biofeedback Therapy for Panic Disorder NCT02826096	National Taiwan University Hospital	N/A
Completed	Providing Tools for Effective Care and Treatment of Anxiety Disorders NCT02605668	Technische Universität Dresden	N/A
Completed	Neural Basis of Meal Related Interoceptive Dysfunction in Anorexia Nervosa NCT02615119	Laureate Institute for Brain Research, Inc.	N/A
Completed	Optimizing Exposure Therapy for Anxiety Disorders NCT04048824	University of California, Los Angeles	N/A
Unknown	The Assessment and Treatment of Balance Impairment Using Virtual Reality (VR) in Panic Disorder Patients NCT01677429	Sheba Medical Center	N/A
Unknown	Initial Severity and Antidepressant Efficacy for Anxiety Disorders: an Individual Patient Data Meta-analysis NCT02476136	prof. Peter de Jonge	—
Completed	A 10-Week, Open-Label, Flexible Dose Adaptive Study Evaluating the Efficacy of Vortioxetine in Subjects With P NCT02395510	Siyan Clinical Corporation	Phase 4
Completed	Transdiagnostic Psychotherapy for Veterans With Mood and Anxiety Disorders NCT01947647	VA Office of Research and Development	N/A
Completed	Project Collabri for Treatment of Anxiety NCT02678624	Amager Hospital	N/A
Completed	Building an Outcomes Assessment Infrastructure to Assess Anxiety Treatment NCT02305537	Mclean Hospital	N/A
Completed	Transdiagnostic iCBT for Depression and Anxiety NCT02266693	Centre for Addiction and Mental Health	N/A
Completed	Predictors and Moderators of Cognitive-Behavioral Therapy and Acceptance and Commitment Therapy for Panic Diso NCT05462184	University of Alcala	N/A
Completed	ACT-smart: Smartphone-supplemented iCBT for Social Phobia and/or Panic Disorder NCT01963806	Stockholm University	N/A
Completed	Using the Canary Breathing System for Panic Disorder Patients NCT01955954	Palo Alto Health Sciences, Inc.	N/A
Completed	Internet-based Self-help Treatment for Panic Disorder: Two Ways of Complementary Psychological Support NCT02402322	Universitat Autonoma de Barcelona	N/A
Unknown	Attention Retraining for Anxiety Disorder Patients Resistent to Antidepressants NCT01906268	Hospital de Clinicas de Porto Alegre	N/A
Completed	Effectiveness of Six Sessions CBT for Adolescents With Emotional Problems in Community Clinics NCT02150265	University of Tromso	N/A
Terminated	D-cycloserine Augmented CBT for Panic Disorder NCT01680107	University of Oxford	Phase 3
Completed	Cortisol Evaluation in Abuse Survivors NCT01632553	University of Bristol	—
Completed	Online Treatments for Mood and Anxiety Disorders in Primary Care NCT01482806	University of Pittsburgh	Phase 2 / Phase 3
Unknown	A Long-term Observational Study on the Efficacy of SSRIs or Combined Treatment(SSRIs+ CBT) in Panic Disorder P NCT01674673	Samsung Medical Center	—
Completed	Escitalopram Trial for Irritable Bowel Syndrome (IBS) Patients With Panic Disorder NCT01551225	Maastricht University Medical Center	Phase 4
Completed	Efficacy and Mechanisms of Psychosocial Treatments for Panic Disorder NCT04366011	Southern Methodist University	N/A
Unknown	Improving Access To Services to Community Based Outpatient Clinics (CBOC's) NCT01346241	Michael E. DeBakey VA Medical Center	N/A
Completed	Physical Activity and Cognitive Behavioural Therapy in Panic Disorder and Agoraphobia NCT01928810	Charite University, Berlin, Germany	N/A
Completed	Neural Effects of Cognitive-behaviour Therapy in Panic Disorder NCT03251235	University of Oxford	N/A
Completed	A Collaborative Care Program to Improve Treatment of Depression and Anxiety Disorders in Cardiac Patients NCT01201967	Massachusetts General Hospital	Phase 4
Completed	False Safety Behavior Elimination Therapy: A Randomized Study of a Brief Individual Transdiagnostic Treatment NCT02082561	Florida State University	N/A
Completed	LUCHAR - Latinos Using Counseling for Help With Asthma and Anxiety Reduction NCT01583296	Albert Einstein College of Medicine	N/A
Completed	Ziprasidone in Bipolar Disorder With Comorbid Lifetime Panic or Generalized Anxiety Disorder(GAD) NCT01172652	VA Palo Alto Health Care System	Phase 4
Unknown	Mechanisms of Panic Disorders Treatment NCT01323556	University Medicine Greifswald	Phase 2 / Phase 3
Terminated	Treatment of Panic Disorder Via Internet With a Wireless Temperature Biofeedback Ring NCT01671033	Chimei Medical Center	N/A
Active Not Recruiting	Outcomes of Cognitive Behavioral Therapy (CBT) Interventions Provided by Unlicensed Professionals NCT01075672	Massachusetts General Hospital	N/A
Withdrawn	Investigation of Neuro-hormonal Mechanisms of Hunger, Fullness and Obesity. NCT01008371	Medical University of South Carolina	—
Terminated	CO2 Inhalation and Risk for Panic Disorder NCT00930657	National Institute of Mental Health (NIMH)	—
Completed	Physical Activity and Cognitive Behavioural Therapy in Panic Disorder NCT01788800	Charite University, Berlin, Germany	N/A
Completed	Efficacy of Aerobic Exercise Added to Alprazolam in Panic Disorder Treatment NCT00803400	University of Buenos Aires	Phase 4
Completed	Virtual Reality Exposure Therapy in Agoraphobic Participants NCT00734370	VU University of Amsterdam	N/A
Completed	Study of the Changes in Metabolic Parameters in Patients Treated With Escitalopram for Six Months NCT00711737	Changi General Hospital	—
Completed	The Influence of the Menstrual Cycle on Lithium and Sertraline Blood Levels NCT01385709	Weill Medical College of Cornell University	—
Terminated	Ramelteon for Sleep Initiation Insomnia in Individuals With Panic Disorder Who Are Also on Escitalopram for An NCT00746239	Milton S. Hershey Medical Center	N/A
Terminated	Org 25935 Versus Placebo as Augmentation to Cognitive-behavioral Therapy to Treat Panic Disorder (P05705) NCT00725725	Merck Sharp & Dohme LLC	Phase 2
Terminated	Treatment of Panic Disorder Via Internet With a Wireless Temperature Biofeedback Ring NCT00825136	Chimei Medical Center	N/A
Completed	Quetiapine in Co-Morbid Depressive and Anxiety Disorders NCT00688818	Centre for Addiction and Mental Health	N/A
Completed	A Study Of Sertraline Compared With Paroxetine In The Treatment Of Panic Disorder NCT00677352	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	Phase 4
Completed	Exposure, D-Cycloserine Enhancement, and Genetic Modulators in Panic Disorder NCT00790868	Boston University Charles River Campus	Phase 2
Completed	Treatment of Social Phobia and Panic Disorder in Adults NCT00619138	Haukeland University Hospital	Phase 3
Completed	Addressing Help-Seeking Barriers in Developing an Intensive Treatment for Veterans With Panic Disorder NCT00628979	US Department of Veterans Affairs	N/A
Completed	Special Drug Use Investigation for PAXIL Tablet (Pediatric Panic Disorder) NCT01376128	GlaxoSmithKline	—
Completed	A Study of Quetiapine SR (Seroquel SR) to Treat SSRI-Resistant, Comorbid Panic Disorder Patients NCT00619892	Indiana University	Phase 4
Completed	Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Panic Disorder With Comorbid Major Dep NCT00521352	New York State Psychiatric Institute	Phase 2
Completed	Neural Functioning Underlying Anxiety and Its Treatment (The INSULA Study) NCT00947570	University of California, San Diego	N/A
Completed	Special Investigation Of Long Term Use Of Sertraline. NCT00605813	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	—
Completed	Evaluating the Effects of Stress in Pregnancy NCT00525226	Emory University	—
Completed	Quetiapine SR and Divalproex Sodium ER in the Treatment of Anxiety in Bipolar Disorder With Panic Disorder and NCT00579280	University of South Florida	Phase 4
Completed	Evaluating the Relationship Between Tobacco Use, Anxiety Sensitivity, and Panic in Adolescents NCT00535964	University of Arkansas, Fayetteville	—
Completed	Physical Exercise Versus Cognitive-behavioral Therapy (CBT) for Panic Disorders: A Randomised Controlled Trial NCT01076777	University of Bergen	Phase 2
Completed	Adventure: Teacher Delivered Personality-targeted Interventions for Substance Misuse NCT00776685	King's College London	Phase 2 / Phase 3
Completed	Special Investigation Of J Zoloft For Panic Disorder Patients NCT00605917	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	—
Completed	Drug Use Investigation of Jzoloft. NCT00605865	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	—
Completed	Changes of Cerebral Glucose Metabolism and After 12 Weeks of Escitalpram Treatment in Panic Disorder NCT00767871	Samsung Medical Center	Phase 4
Completed	Changes of Cerebral Glucose Metabolism After 12 Weeks of Paroxetine Treatment in Panic Disorder NCT00767754	Samsung Medical Center	Phase 4
Completed	Study of Brain Circuitry in Anxiety Disorders NCT01849432	Mclean Hospital	—
Completed	Comparison of Psychotherapy Programs to Treat Panic Disorder NCT00353470	Weill Medical College of Cornell University	Phase 3
Completed	The Efficacy and Tolerability of Duloxetine for the Treatment of Panic Disorder NCT00438971	Massachusetts General Hospital	Phase 4
Completed	Primary Care Intervention Strategy for Anxiety Disorders NCT00347269	University of Washington	Phase 4
Completed	Cognitive Behavior Psychotherapy in Panic Disorder NCT01025908	Universidade Federal do Rio de Janeiro	N/A
Terminated	ELB139 Given Orally to Patients With Concurrent Panic Disorder, Challenged by CO2 Inhalation After a Single Do NCT00322803	elbion AG	Phase 2
Completed	Special Drug Use Investigation for PAXIL Tablet (Investigation in Case of Administered From 20mg/Day) NCT01371474	GlaxoSmithKline	—
Completed	Cognitive Behavioral Therapy in Panic Disorder NCT00772746	Universidade Federal do Rio de Janeiro	—
Completed	Treatment of Late-life Anxiety in Primary Care Settings NCT00938093	Wake Forest University Health Sciences	N/A
Completed	Trial of Seroquel SR for Alcohol Dependence and Comorbid Anxiety NCT00352469	Creighton University	Phase 4
Completed	Levetiracetam Treatment of Panic Disorder and Lactate-Induced Panic Attacks NCT00279617	Lindner Center of HOPE	Phase 3
Unknown	Genetic Abnormalities and Biological Changes of Panic Disorder Patients After Pharmacotherapy NCT00515996	Samsung Medical Center	—
Completed	Trial to Compare Time to Response in the Symptoms of Anxiety to Concomitant Treatment With Niravam™ and an SSR NCT00266409	UCB Pharma	Phase 4
Unknown	Treatment of Panic Disorder Among Individuals Consulting Emergency Departments for Non Cardiac Chest Pain NCT00736346	Université du Québec a Montréal	N/A
Completed	Aripiprazole for the Treatment of Refractory Anxiety NCT00438386	Massachusetts General Hospital	Phase 4
Completed	Breathing Regulation Training for Individuals With Panic Disorder NCT00183521	Stanford University	N/A
Completed	Effectiveness of Intensive Cognitive Behavioral Therapy in Treating Adolescent Panic Disorder and Agoraphobia NCT00576719	Boston University	Phase 2
Completed	Neurobiological Mechanisms in Panic Disorder NCT00103987	National Institute of Mental Health (NIMH)	—
Completed	Internet-Versus Group-Administered Cognitive Behavior Therapy for Panic Disorder NCT00845260	Karolinska Institutet	Phase 3
Completed	Augmenting Exposure Therapy With an N-Methyl-D-Aspartate (NMDA) Agonist for Panic Disorder NCT00131339	Hartford Hospital	N/A
Completed	Evaluation of Substance P Neurotransmission in Panic Disorder by PET Imaging of NK1 Receptors With [18F]SPA-RQ NCT00088738	National Institute of Mental Health (NIMH)	Phase 1
Terminated	A Study to Assess the Long-term Use of Alprazolam Extended Release (XL) in the Treatment of Adolescents With P NCT00635076	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	Phase 4
Completed	Genetic Causes of Panic Disorder NCT00083265	National Institute of Mental Health (NIMH)	—
Terminated	A Study To Assess the Safety of Extended Release Alprazolam for the Treatment of Adolescents With Panic Disord NCT00634790	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	Phase 4
Terminated	A Study to Evaluate the Use of Extended Release Alprazolam in the Treatment of Adolescents With Panic Disorder NCT00635531	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	Phase 4
Completed	Levetiracetam for the Treatment of Alcohol Dependence and Anxiety NCT00141115	New York State Psychiatric Institute	Phase 2
Completed	Telephone-Based Care Management Program for Individuals With Anxiety Disorders NCT00158327	University of Pittsburgh	Phase 3
Unknown	Study of Virtual Reality Therapy and Cognitive Behavior Therapy in Panic Disorder With Agoraphobia NCT00129610	Hospices Civils de Lyon	N/A
Completed	A Study of Sertraline and Early Alprazolam XR Administration Versus Sertraline Only in Panic Disorder Patients NCT00198094	Indiana University School of Medicine	Phase 4
Completed	Personality-targeted Interventions for Adolescent Alcohol Misuse NCT00344474	King's College London	Phase 2 / Phase 3
Completed	A Study of Risperidone Monotherapy in Bipolar Anxiety NCT00167479	University of South Florida	Phase 4
Completed	Efficacy of Treatment for Panic Disorder NCT00456768	University of British Columbia	—
Terminated	Risperidone vs. Paroxetine for Panic Attacks NCT00206765	Beth Israel Medical Center	Phase 2
Completed	Therapy for Depression With Co-occurring Panic or Anxiety Symptoms NCT00051207	University of Pittsburgh	Phase 1 / Phase 2
Terminated	Sertraline in Generalized Social Phobia With Co-Occurring Anxiety and Mood Disorders NCT00182533	Hamilton Health Sciences Corporation	Phase 4
Completed	A Single-Blind Trial of Risperidone vs. Paroxetine for Treatment of Panic Attacks NCT00457106	Beth Israel Medical Center	N/A
Unknown	Panic Disorder and Cardiac Risk NCT00168506	Baker Heart Research Institute	N/A
Completed	Evaluation of Clonazepam and Paroxetine for Panic Disorder With Depression NCT00031317	National Institute of Mental Health (NIMH)	Phase 4
Completed	Interactive Computer Treatment for Panic Disorder NCT00063375	Florida State University	Phase 1
Completed	Ventilatory Physiology in Children at Risk for Anxiety NCT00101777	National Institute of Mental Health (NIMH)	—
Completed	Study Evaluating Venlafaxine ER in Patients With Panic Disorder NCT00044772	Wyeth is now a wholly owned subsidiary of Pfizer	Phase 3
Completed	Brain Chemical Receptor Effects in Patients With Panic Disorder and Post-Traumatic Stress Disorder NCT00025974	National Institute of Mental Health (NIMH)	—
Completed	Paroxetine vs Placebo Combined With Aerobic Exercise or Relaxation in Panic Disorder NCT00540098	University of Göttingen	Phase 4
Completed	Study Evaluating Venlafaxine ER in Adults With Panic Disorder NCT00038896	Wyeth is now a wholly owned subsidiary of Pfizer	Phase 3
Completed	Improving Quality of Primary Care for Patients With Anxiety and/or Panic Disorders NCT00102427	University of Pittsburgh	Phase 2 / Phase 3
Completed	Vestibular Dysfunction In Adult Patients With Panic Disorder With or Without Agoraphobia NCT00004367	National Center for Research Resources (NCRR)	N/A
Completed	Psychodynamic Therapy for Treating Panic Disorder NCT00128388	Weill Medical College of Cornell University	Phase 2 / Phase 3
Completed	Long Term Treatment of Panic Disorder With Clonazepam or Paroxetine NCT02852577	Universidade Federal do Rio de Janeiro	Phase 4
Completed	Therapies for Treatment-Resistant Panic Disorder Symptoms NCT00118417	Massachusetts General Hospital	Phase 2 / Phase 3
Completed	Treatment of Panic Disorder: Long Term Strategies NCT00000368	New York State Psychiatric Institute	Phase 3
Completed	Effectiveness of Cognitive Behavioral Therapy With Panic Control Treatment for Adolescents With Panic Disorder NCT00705380	Boston University	Phase 2
Completed	Randomized Study of Cognitive-Behavioral Therapy vs Imipramine and Their Combination for Panic Disorder NCT00004834	Northwell Health	N/A
Completed	Phase II Double-Blind, Placebo-Controlled Study of the Reinforcing Effects of Alprazolam in Patients With Anxi NCT00004373	National Institute on Drug Abuse (NIDA)	Phase 2
Completed	Pilot Study of Vestibular Rehabilitation Training for Panic Disorder With Vestibular Dysfunction NCT00004366	National Center for Research Resources (NCRR)	N/A
Unknown	Costs of Lost Productive Time Among Korean Workers With Panic Disorder and Effect of Treatment With Paroxetine NCT00492414	Inje University	Phase 4